Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
Status:
Completed
Trial end date:
2018-11-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the capability of the dPCR technique to predict the
absence of disease relapses after imatinib discontinuation in CML patients with negative
Q-RT-PCR results for longer than 18 months.